Eslipel Met
Sitagliptin and Metformin act in a complementary manner and provide many benefits: improved glycemic control, no body weight increase, low risk of hypoglycemia, and improved adherence to treatment.
Therapeutic Area
Type-2 Diabetes
Active Ingredient
Metformin + Sitagliptin
Line
Cardiometabolism + Diabetes + Endocrinology + Medical Clinic
Presentation
50 mg/ 850 mg x 60 tablets
50 mg/ 1000 mg x 30 and 60 tablets
